Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-24

Clinical Trial Update: Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing solifenacin and mirabegron for overactive bladder symptoms in men after TURP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • Solifenacin (solifenacin)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Overactive Bladder Syndrome | Phase 2 | Status: UNKNOWN